V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003955 | 10002495 | 1.71 | 89.6 | Curative (C) | 2013-07-04 | 2013-07-04 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10502374 | ABIRATERONE |
| 10003956 | 10002496 | 1.82 | 84.3 | Palliative (P) | 2016-12-21 | 2016-12-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10502400 | CAPECITABINE + GEMCITABINE |
| 10003957 | 10002496 | 1.58 | null | Curative (C) | 2018-02-03 | 2018-02-18 | Temozolomide + RT | N | N | 10502400 | BORTEZOMIB |
| 10003958 | 10002497 | 1.55 | 65 | Palliative (P) | 2017-08-31 | 2017-09-01 | FLUOROURACIL + IRINOTECAN | N | N | 10502474 | IRINOTECAN + MDG |
| 10003959 | 10002498 | null | null | Disease modification (D) | 2017-05-31 | 2017-06-28 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10502485 | FLUOROURACIL + MITOMYCIN + RT |
| 10003960 | 10006547 | null | null | Adjuvant (A) | 2018-10-09 | 2018-10-10 | FEC + DOCETAXEL | 2 | N | 10502536 | FEC + DOCETAXEL |
| 10003961 | 10002499 | 1.63 | 64 | Palliative (P) | 2019-01-27 | 2019-02-10 | Temozolomide + RT | 02 | N | 10502545 | CHLORAMBUCIL |
| 10003962 | 10002500 | 1.69 | 55 | Adjuvant (A) | 2016-05-16 | 2016-05-16 | Abiraterone | N | N | 10502575 | BORTEZOMIB |
| 10003963 | 10002501 | 1.8 | 76 | Curative (C) | 2017-08-08 | 2017-08-13 | Temozolomide + RT | N | N | 10502588 | IMATINIB |
| 10003964 | 10002501 | 1.67 | 90 | Curative (C) | 2018-03-17 | 2018-04-12 | Capecitabine + Cisplatin | N | N | 10502588 | CAPECITABINE + CISPLATIN |
| 10003965 | 10002502 | 1.65 | 62.9 | Curative (C) | null | 2018-05-14 | Fluorouracil+Mitomycin+RT (Bladder) | N | N | 10502611 | IMATINIB |
| 10003966 | 10002502 | null | 100.5 | Curative (C) | null | 2017-07-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | N | 10502611 | CISPLATIN |
| 10003967 | 10002502 | 1.87 | 76 | Disease modification (D) | 2016-12-17 | 2016-12-17 | Chlorambucil | 2 | N | 10502611 | BORTEZOMIB |
| 10003968 | 10002502 | 1.65 | 100 | Neo-adjuvant (N) | null | 2016-02-27 | Cisplatin | N | N | 10502611 | EC |
| 10003969 | 10002502 | 1.76 | 61.5 | Curative (C) | 2017-11-12 | 2017-11-17 | ABVD | N | N | 10502611 | PACLITAXEL |
| 10003970 | 10002503 | 1.59 | null | Not known (9) | 2018-07-22 | 2018-08-03 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10502964 | BORTEZOMIB |
| 10003971 | 10002504 | 1.6 | null | Adjuvant (A) | 2016-12-01 | 2016-12-23 | CTD | N | N | 10503009 | EC |
| 10003972 | 10002505 | 1.71 | null | Disease modification (D) | 2018-02-28 | 2018-03-04 | Cisplatin 7 day | Y | N | 10503093 | CISPLATIN + ETOPOSIDE |
| 10003973 | 10002506 | 1.78 | 75 | Disease modification (D) | 2016-07-05 | 2016-07-06 | Capecitabine + Cisplatin | N | N | 10503151 | CTD |
| 10003974 | 10002507 | 1.57 | 110 | Curative (C) | 2018-04-07 | 2018-04-14 | CYCLOPHOSPHAMIDE + EPIRUBICIN | N | N | 10503264 | TEMOZOLOMIDE + RT |
| 10003975 | 10002507 | 1.73 | null | Neo-adjuvant (N) | 2016-07-31 | 2016-08-04 | Fluorouracil + Folinic Acid Weekly | N | N | 10503264 | FLUOROURACIL |
| 10003976 | 10002507 | 1.65 | 78.1 | Palliative (P) | 2016-09-06 | 2016-09-26 | Cisplatin | N | N | 10503264 | ABIRATERONE |
| 10003977 | 10002508 | null | null | Palliative (P) | 2015-04-21 | 2015-05-08 | Irinotecan + Modified De Gramont | N | N | 10503341 | IRINOTECAN + MDG |
| 10003978 | 10002508 | 1.71 | 71.2 | Adjuvant (A) | 2014-02-20 | 2014-02-26 | FEC 100 + DOCETAXEL | N | N | 10503341 | FEC + DOCETAXEL |
| 10003979 | 10002509 | null | 85.4 | Curative (C) | 2013-10-28 | 2013-11-03 | Chlorambucil | N | N | 10503453 | FLUOROURACIL + MITOMYCIN + RT |
| 10003980 | 10002510 | null | 78 | Adjuvant (A) | 2019-03-26 | 2019-03-26 | EC | N | N | 10503469 | CAPECITABINE + CISPLATIN |
| 10003981 | 10002511 | 1.7 | 75 | Curative (C) | 2014-06-26 | 2014-06-26 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | Y | 10503575 | IMATINIB |
| 10003982 | 10002512 | 1.68 | 70.4 | Neo-adjuvant (N) | 2017-02-19 | 2017-02-26 | Capecitabine 35days + RT | 02 | Y | 10503638 | CAPECITABINE + RT |
| 10003983 | 10002513 | 1.6 | 62.9 | Palliative (P) | 2017-11-18 | 2017-12-08 | Irinotecan + Modified De Gramont | 02 | N | 10503716 | IRINOTECAN + MDG |
| 10003984 | 10002514 | 0 | 60 | Neo-adjuvant (N) | 2014-12-22 | 2014-12-27 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 10503989 | BCG |
| 10003985 | 10002515 | 1.6 | 57.5 | Palliative (P) | 2019-08-11 | 2019-08-18 | Cisplatin + Etoposide (3 day) | N | N | 10503990 | CVD |
| 10003986 | 10002515 | null | 81.4 | Adjuvant (A) | 2017-12-05 | 2017-12-12 | Capecitabine 35days + RT | 02 | N | 10503990 | CAPECITABINE + RT |
| 10003987 | 10002515 | 1.72 | null | Adjuvant (A) | null | 2017-11-20 | Abiraterone | 99 | N | 10503990 | CAPECITABINE + GEMCITABINE |
| 10003988 | 10002515 | 1.78 | 69 | Curative (C) | 2017-02-12 | 2017-03-05 | Cisplatin 7 day | 02 | N | 10503990 | AZACITIDINE |
| 10003989 | 10002516 | 1.71 | 86 | Curative (C) | 2016-11-29 | 2016-12-15 | Paclitaxel 80mg/m2 day 1 8 15 | N | Y | 10504104 | AZACITIDINE |
| 10003990 | 10002517 | 1.83 | 75.6 | Curative (C) | 2016-08-01 | 2016-08-03 | Temozolomide + RT | N | N | 10504112 | PACLITAXEL |
| 10003991 | 10002518 | 1.63 | 55 | Palliative (P) | 2017-02-09 | 2017-02-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 10504185 | AZACITIDINE |
| 10003992 | 10006553 | 1.73 | 86.8 | Palliative (P) | 2016-07-02 | 2016-07-23 | Cisplatin 7 day | 2 | Y | 10504193 | CTD |
| 10003993 | 10002519 | 1.78 | null | Palliative (P) | null | 2016-06-14 | Imatinib 400mg | N | N | 10504239 | AZACITIDINE |
| 10003994 | 10002519 | 1.57 | 79.2 | Palliative (P) | 2017-10-31 | 2017-10-31 | Gemcitabine + Capecitabine | 2 | N | 10504239 | CHOP |
| 10003995 | 10002519 | 1.84 | 0 | Disease modification (D) | 2015-11-01 | 2015-11-01 | CTD Attenuated (Thalidomide 50mg) | 2 | Y | 10504239 | BORTEZOMIB |
| 10003996 | 10002520 | 1.63 | 55 | Neo-adjuvant (N) | 2017-12-16 | 2017-12-16 | Abiraterone | 02 | N | 10504301 | BCG |
| 10003997 | 10006555 | 1.78 | 83.3 | Adjuvant (A) | 2016-10-14 | 2016-11-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | 10504311 | CVD |
| 10003998 | 10002521 | 1.88 | 91.05 | Adjuvant (A) | null | 2017-12-05 | Gemcitabine + Capecitabine | N | null | 10504393 | ABVD |
| 10003999 | 10006556 | 1.78 | 87 | Disease modification (D) | 2018-11-18 | 2018-12-11 | PACLITAXEL | 02 | N | 10504431 | BCG |
| 10004000 | 10002522 | 1.58 | 79 | Adjuvant (A) | 2017-02-19 | 2017-03-02 | EC | 02 | N | 10504433 | EC |
| 10004001 | 10002523 | 1.61 | null | Palliative (P) | 2017-12-21 | 2017-12-25 | EC | null | N | 10504440 | EC |
| 10004002 | 10006557 | 1.62 | 77.8 | Palliative (P) | 2018-03-01 | 2018-03-07 | Bortezomib + Cyclophos + Dex | N | N | 10504484 | PACLITAXEL |
| 10004003 | 10002524 | 1.73 | 108 | Palliative (P) | 2017-07-14 | 2017-07-24 | Bortezomib (weekly) | null | N | 10504492 | BCG |
| 10004004 | 10002525 | 1.8 | 71 | Palliative (P) | 2018-07-16 | 2018-08-06 | CHOP - 21 days | N | N | 10504507 | CAPECITABINE + CISPLATIN |